Skip to header Skip to main navigation Skip to main content Skip to footer
Home
Academic Citations from Palestine
Foregrounding the Research of Academics in Palestine

Main navigation

  • Home
  • Search
  • About

Combination of Somatostatin and Rectal Nonsteroidal Anti-Inflammatory Drugs for Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients: A Meta-Analysis of Randomized Controlled Trials

Blank
Al-Azhar University – Gaza
Jaber F.; Salahat A.-J.; Alsakarneh S.; Alsharaeh T.; Jaber M.; Gangwani M.K.; Mohamed I.; Aldiabat M.; Kilani Y.; ALi H.; Ghoz H.
Jaber, Fouad (57927659200); Salahat, Ahmed-Jordan (58791133800); Alsakarneh, Saqr (57919358400); Alsharaeh, Tala (58791721900); Jaber, Mohammad (58774780400); Gangwani, Manesh Kumar (57196117639); Mohamed, Islam (58299799300); Aldiabat, Mohammad (57218678146); Kilani, Yassine (57556786600); ALi, Hassam (57221081047); Ghoz, Hassan (56313137100)
57927659200; 58791133800; 57919358400; 58791721900; 58774780400; 57196117639; 58299799300; 57218678146; 57556786600; 57221081047; 56313137100
2024
American Journal of Therapeutics
Combination of Somatostatin and Rectal Nonsteroidal Anti-Inflammatory Drugs for Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients: A Meta-Analysis of Randomized Controlled Trials
31
5
e628
e633
Lippincott Williams and Wilkins
Department of Internal Medicine, University of Missouri Kansas City, Kansas City, MO, United States; Department of Medicine, The University of Jordan, Faculty of Medicine, Amman, Jordan; Faculty of Medicine, Al-Azhar University, Gaza, Palestine; Department of Internal Medicine, University of Toledo, Toledo, OH, United States; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, United States; Department of Epidemiology, Harvard School of Public Health, Boston, MA, United States; Department of Internal Medicine, NYC Health + Hospitals, Lincoln - Weill Cornell Medical College, Bronx, NY, United States; Department of Gastroenterology, ECU Health Medical Center, Greenville, NC, United States; Division of Gastroenterology and Hepatology, University of Missouri Kansas City, Kansas City, MO, United States
Jaber F., Department of Internal Medicine, University of Missouri Kansas City, Kansas City, MO, United States; Salahat A.-J., Department of Medicine, The University of Jordan, Faculty of Medicine, Amman, Jordan; Alsakarneh S., Department of Internal Medicine, University of Missouri Kansas City, Kansas City, MO, United States; Alsharaeh T., Department of Medicine, The University of Jordan, Faculty of Medicine, Amman, Jordan; Jaber M., Faculty of Medicine, Al-Azhar University, Gaza, Palestine; Gangwani M.K., Department of Internal Medicine, University of Toledo, Toledo, OH, United States; Mohamed I., Department of Internal Medicine, University of Missouri Kansas City, Kansas City, MO, United States; Aldiabat M., Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, United States, Department of Epidemiology, Harvard School of Public Health, Boston, MA, United States; Kilani Y., Department of Internal Medicine, NYC Health + Hospitals, Lincoln - Weill Cornell Medical College, Bronx, NY, United States; ALi H., Department of Gastroenterology, ECU Health Medical Center, Greenville, NC, United States; Ghoz H., Division of Gastroenterology and Hepatology, University of Missouri Kansas City, Kansas City, MO, United States
1
10.1097/MJT.0000000000001734
Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Drug Therapy, Combination; Humans; Pancreatitis; Randomized Controlled Trials as Topic; Somatostatin; nonsteroid antiinflammatory agent; somatostatin; nonsteroid antiinflammatory agent; somatostatin; endoscopic retrograde cholangiopancreatography; high risk patient; human; hyperamylasemia; Letter; meta analysis; pancreatitis; adverse event; combination drug therapy; etiology; pancreatitis; prevention and control; randomized controlled trial (topic); rectal drug administration